trending Market Intelligence /marketintelligence/en/news-insights/trending/nqddal3z7pl3prdjwzoaeq2 content esgSubNav
In This List

T2 Biosystems prices common stock offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


T2 Biosystems prices common stock offering

Lexington, Mass.-based T2 Biosystems Inc. priced an underwritten registered public offering of 6.1 million common shares at $7.50 per share.

T2 Biosystems expects $45.8 million in gross proceeds from the offering, which is expected to close by June 4.

Leerink Partners LLC is acting as the book-running manager for the offering while Canaccord Genuity LLC is acting as the passive book-running manager.

Janney Montgomery Scott LLC, JonesTrading Institutional Services LLC and WBB Securities LLC are acting as co-managers.

The underwriters can buy up to an additional 915,000 common shares from the company.